Abstract | AIMS: METHODS: The disposition of piperaquine was studied in 85 Cambodian patients with uncomplicated falciparum or vivax malaria treated with the piperaquine- dihydroartemisinin coformulation Artekin. All patients were given Artekin orally at 0, 6, 24 and 32 h with a total piperaquine dose of 32-35 mg base kg-1. Adults were given tablets while children received either tablets or a dispersible granule formulation. Patients underwent either intensive (17-19 samples) or sparse (2-5 samples) blood sampling schedules over 35 days and clinical/parasitological follow-up over > 28 days. Piperaquine in plasma was quantified by high performance liquid chromatography. RESULTS: All patients achieved fever clearance within 24 h and parasite clearance within 72 h. The 28-day cure rate was 97% in adults and 98% in children. A covariate-free two-compartment population model with first-order absorption and elimination gave the most robust representation of the plasma concentration-time data in both adults and children. In adults (n = 38), the median (interquartile range) derived pharmacokinetic descriptors CL/F, Vss/F and t1/2,z were 0.9 l h-1 kg-1 (0.79-1.02 l h-1 kg-1), 574 l kg-1(371-711 l kg-1) and 23 days (19-28 days), respectively. In children (n = 47), corresponding values were 1.8 l h-1 kg-1 (1.29-2.3 l h-1 kg-1), 614 l kg-1 (332-1205 l kg-1) and 14 days (10-18 days), respectively. CONCLUSIONS:
Piperaquine is a highly lipid-soluble drug with a large Vss/F, long t1/2,z and a clearance that is markedly higher in children than in adults.
|
Authors | Te-Yu Hung, Timothy M E Davis, Kenneth F Ilett, Harin Karunajeewa, Sean Hewitt, Mey Bouth Denis, Chiv Lim, Doung Socheat |
Journal | British journal of clinical pharmacology
(Br J Clin Pharmacol)
Vol. 57
Issue 3
Pg. 253-62
(Mar 2004)
ISSN: 0306-5251 [Print] England |
PMID | 14998421
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimalarials
- Quinolines
- Tablets
- piperaquine
|
Topics |
- Adult
- Antimalarials
(pharmacokinetics, therapeutic use)
- Child
- Dose-Response Relationship, Drug
- Female
- Humans
- Malaria, Falciparum
(blood, drug therapy)
- Malaria, Vivax
(blood, drug therapy)
- Male
- Quinolines
(pharmacokinetics, therapeutic use)
- Tablets
|